<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01586663</url>
  </required_header>
  <id_info>
    <org_study_id>CEP 1070/09</org_study_id>
    <nct_id>NCT01586663</nct_id>
  </id_info>
  <brief_title>Serial Night Time Position Splint on Systemic Sclerosis</brief_title>
  <official_title>Evaluation of Serial Night Time Position Splint on Range of Motion for Patients With Systemic Sclerosis</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Federal University of S達o Paulo</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Federal University of S達o Paulo</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      This is a randomized controlled trial with blinded evaluator and follow-up of one year.
      Seventy six patients with diffuse systemic sclerosis, will be randomized into two groups.The
      patients can not change their medication during the study. Patients will be evaluated at
      baseline and at 3, 6, 9 and 12 months. The experimental group will use a serial night time
      position splint who will be adjusted monthly, while the control group will remain the drug
      treatment. The outcomes assessed will be: pain, hand range of motion, quality of life,
      functional capacity, upper limb function and dexterity. Our hypothesis is that the serial
      night time position splint will improve the hand range of motion in diffuse systemic
      sclerosis patients.
    </textblock>
  </brief_summary>
  <overall_status>Unknown status</overall_status>
  <last_known_status>Recruiting</last_known_status>
  <start_date>January 2010</start_date>
  <completion_date type="Anticipated">December 2012</completion_date>
  <primary_completion_date type="Anticipated">December 2012</primary_completion_date>
  <phase>Phase 3</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Single (Outcomes Assessor)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Change in hand range of motion</measure>
    <time_frame>Baseline and after 3, 6, 9 and 12 months</time_frame>
    <description>Measured by goniometry</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Change in pain</measure>
    <time_frame>Baseline, after 10, 20 and 40 weeks</time_frame>
    <description>Measured by a visual analogue scale</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Change in functional capacity</measure>
    <time_frame>Baseline, after 10, 20 and 40 weeks</time_frame>
    <description>Measured by HAQ questionnaire</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Change in quality of life</measure>
    <time_frame>Basline, after 10, 20 and 40 weeks</time_frame>
    <description>Measured by SF-36 questionnaire</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Change in upper limb function</measure>
    <time_frame>Baseline, after 10, 20 and 40 weeks</time_frame>
    <description>Measured by DASH questionnaire</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Change in dexterity</measure>
    <time_frame>Baseline, after 3, 6, 9 and 12 months</time_frame>
    <description>Measured by SODA test</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">76</enrollment>
  <condition>Diffuse Systemic Sclerosis</condition>
  <arm_group>
    <arm_group_label>Experimental Group</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Splint group</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Control Group</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Drug treatment</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Serial night time position splint</intervention_name>
    <description>This group will use a serial night time position splint, adjusted monthly, during three months.</description>
    <arm_group_label>Experimental Group</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Drug treatment</intervention_name>
    <description>This patients will keep there drug treatment and will receive their splints on the end of the study.</description>
    <arm_group_label>Control Group</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Diffuse Systemic scleroses diagnosed following the ACR criteria

          -  Older than 18 years old

          -  Sclerodactyly

        Exclusion Criteria:

          -  Neurological, psychiatric diseases and other rheumatic disease (including overlapping)

          -  Previous use of splints or allergy to splint material

          -  Surgery schedule to the next 12 months
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Jamil Natour, PhD</last_name>
    <role>Study Chair</role>
    <affiliation>Federal University of S達o Paulo</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Fernanda P Cardoso, OT</last_name>
    <phone>551155764239</phone>
    <email>anamajones@gmail.com</email>
  </overall_contact>
  <location>
    <facility>
      <name>Universidade Federal de Sao Paulo</name>
      <address>
        <city>Sao Paulo</city>
        <state>SP</state>
        <zip>04023-062</zip>
        <country>Brazil</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Fernanda P Cardosos, OT</last_name>
      <phone>551155764239</phone>
      <email>anamajones@gmail.com</email>
    </contact>
    <investigator>
      <last_name>Jamil Natour, PhD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Paula G Silva, MsC</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Anamaria Jones, PhD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>Brazil</country>
  </location_countries>
  <verification_date>April 2012</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>April 25, 2012</study_first_submitted>
  <study_first_submitted_qc>April 26, 2012</study_first_submitted_qc>
  <study_first_posted type="Estimate">April 27, 2012</study_first_posted>
  <last_update_submitted>April 27, 2012</last_update_submitted>
  <last_update_submitted_qc>April 27, 2012</last_update_submitted_qc>
  <last_update_posted type="Estimate">May 1, 2012</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Federal University of S達o Paulo</investigator_affiliation>
    <investigator_full_name>Fernanda Pontes Cardoso</investigator_full_name>
    <investigator_title>Principal Investigator</investigator_title>
  </responsible_party>
  <keyword>Diffuse Systemic Sclerosis</keyword>
  <keyword>Hand</keyword>
  <keyword>Range of motion</keyword>
  <keyword>Splint</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Sclerosis</mesh_term>
    <mesh_term>Scleroderma, Systemic</mesh_term>
    <mesh_term>Scleroderma, Diffuse</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

